Liquid biopsy-guided selection for anti-EGFR
re-treatment in RAS/BRAF wild-type (wt)
chemorefractory metastatic colorectal cancer patients
(mCRC pts): Results from the phase II randomized
PARERE trial
4O
Clinical utility of including circulating tumor DNA (ctDNA)
monitoring in standard of care (SoC) colorectal cancer (CRC)
surveillance
2O
ESMO GI 2025
COLORRECTAL
Tu canal independiente de oncología en español
Top resúmenes y presentaciones
Regístrate aquí para recibir más contenidos
Registrarse